Literature DB >> 18802096

Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner.

Lin Lan1, Sebastian Gorke, Sibylle J Rau, Mirjam B Zeisel, Eberhard Hildt, Kiyoshi Himmelsbach, Monica Carvajal-Yepes, Roman Huber, Takaji Wakita, Annette Schmitt-Graeff, Cathy Royer, Hubert E Blum, Richard Fischer, Thomas F Baumert.   

Abstract

Apoptosis of infected cells represents a key host defense mechanism against viral infections. The impact of apoptosis on the elimination of hepatitis C virus (HCV)-infected cells is poorly understood. The TRAIL has been implicated in the death of liver cells in hepatitis-infected but not in normal liver cells. To determine the impact of TRAIL on apoptosis of virus-infected host cells, we studied TRAIL-induced apoptosis in a tissue culture model system for HCV infection. We demonstrated that HCV infection sensitizes primary human hepatocytes and Huh7.5 hepatoma cells to TRAIL induced apoptosis in a dose- and time-dependent manner. Mapping studies identified the HCV nonstructural proteins as key mediators of sensitization to TRAIL. Using a panel of inhibitors targeting different apoptosis pathways, we demonstrate that sensitization to TRAIL is caspase-9 dependent and mediated in part via the mitochondrial pathway. Sensitization of hepatocytes to TRAIL-induced apoptosis by HCV infection represents a novel antiviral host defense mechanism that may have important implications for the pathogenesis of HCV infection and may contribute to the elimination of virus-infected hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802096     DOI: 10.4049/jimmunol.181.7.4926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

Review 2.  HIV/hepatitis C coinfection natural history and disease progression.

Authors:  Maria D Hernandez; Kenneth E Sherman
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

3.  Is hepatitis C virus carcinogenic?

Authors:  Stanley M Lemon; David R McGivern
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

4.  Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.

Authors:  Murali Ganesan; Sathish Kumar Natarajan; Jinjin Zhang; Justin L Mott; Larisa I Poluektova; Benita L McVicker; Kusum K Kharbanda; Dean J Tuma; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

5.  Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.

Authors:  T Wang; R V Campbell; M K Yi; S M Lemon; S A Weinman
Journal:  J Viral Hepat       Date:  2010-11       Impact factor: 3.728

6.  Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.

Authors:  Bruno Sainz; Naina Barretto; Susan L Uprichard
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

Review 7.  Caspase inhibitors for the treatment of hepatitis C.

Authors:  Howard C Masuoka; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

Review 8.  Immune cell-mediated liver injury.

Authors:  Nadia Corazza; Anastasia Badmann; Christoph Lauer
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

9.  The Autophagosomal SNARE Protein Syntaxin 17 Is an Essential Factor for the Hepatitis C Virus Life Cycle.

Authors:  Huimei Ren; Fabian Elgner; Bingfu Jiang; Kiyoshi Himmelsbach; Regina Medvedev; Daniela Ploen; Eberhard Hildt
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  Old and rising stars in the lymphoid liver.

Authors:  Carlo Selmi; Mauro Podda; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.